Skip to content
Recall Observatory FDA recall evidence

Drug product

Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-466-99

D-0533-2024

May 10, 2024

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 94606
Status
Ongoing
Classification
Class II
Quantity
11,976 cartons
Official record key
drug-enforcement:D-0533-2024

Official wording

Reason: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Code information: Lot#: 19224217; Exp. 9/2024 Lot#: 19233789; Exp. 9/2025 Lot#: 19224444; Exp. 9/2024

Distribution pattern: US Nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso Desmethyl Rizatriptan Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations